Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case-control study

Clicks: 84
ID: 270175
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In a real-world setting, vedolizumab was demonstrated to have an efficacy and safety profile among elderly IBD patients that were comparable to younger controls.
Reference Key
p2019gastroenterologyefficacy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shashi P;Gopalakrishnan D;Parikh MP;Shen B;Kochhar G;;
Journal Gastroenterology report
Year 2019
DOI
DOI not found
URL
https://www.pubmed.gov/32843978/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:32843978 pmc7434586 doi:10.1093/gastro/goz041 preeti shashi dharmesh gopalakrishnan gursimran kochhar

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.